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In two separate experiments, the bacteriocin,
nisin, was incorporated into a commercially available meat binding system
(Fibrimex®) and applied to meat surfaces as a way of inhibiting the meat spoilage
organism, Brochothrix thermosphacta during extended refrigerated storage. In experiment 1,
pre-rigor lean beef carcass tissue (BCT) was inoculated with B. thermosphacta, left
untreated (U), treated with 10 mg ml−1 nisin (N), Fibrimex® (F) or Fibrimex® containing
10 mg ml−1 nisin (FN), held aerobically at 4 °C for up to 7 d, and populations of B.
thermosphacta and nisin activity determined. Experiment 2 determined the effects of the same
treatments but on post-rigor, frozen and thawed lean BCT that was inoculated, vacuumpackaged, and stored at 4 °C for up to 14 d. In both experiments, N- and FNtreated tissues exhibited significantly lower populations of B. thermosphacta compared
to U- and F-treated tissues, for the duration of refrigerated storage. Nisin activity was
detected up to 7 d in N- and FN-treated samples from experiment 1. However, activity
was detected only to days 0 and 2 in FN- and N-treated samples, respectively,
from experiment 2. These studies indicate that the addition of a bacteriocin to a meat
binding system and application to meat surfaces may be useful in reducing
undesirable bacteria in restructured meat products.
C .N . C U TT ER A ND G. R . S IR A GU SA . 1998.

INTRODUCTION

Generally, small muscles of high quality or lean trimmings
obtained from fabricated beef carcasses are processed into
products with relatively low economic value such as sausages,
meat snacks or raw ground products (Wijngaards and Paardekooper 1988). In the past, these muscle pieces and trimmings of high quality were tumbled with the addition of
salts, phosphates or binding agents, and formed. Recently, a
method has been developed for the preparation of restructured meat products (Paardekooper and Wijngaards 1988;
Wijngaards and Paardekooper 1988). Known as Fibrimex®
(F.N.A. Foods, Calgary, Alberta, Canada), this cold meat
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binding system results from an enzymatic reaction between
the blood proteins, fibrinogen and thrombin, and the meat
components, collagen and fibronectin (Wijngaards and Paardekooper 1988). Fibrimex® is approved in the USA for use
in the meat industry as a means of adhering whole muscle or
pieces of fresh meat, poultry, fish or seafood together into
one piece. Regardless of the method used for compositing,
external beef surfaces of muscles and trim used in restructured meat products may harbour pathogenic or spoilage
bacteria which are then internalized. This observation illustrates the need to investigate methods for decontaminating
external surfaces of meat or muscle destined for internalization in restructured meat products.
The use of bacteriocins, such as nisin, in food systems has
been extensively documented (for a review, see Nettles and
Barefoot 1993). Numerous reports have also addressed the
addition of bacteriocins to intact or processed meat products
as a means of inhibiting pathogenic or spoilage bacteria (Bell
and De Lacy 1986; Chung et al. 1989; Vignolo et al. 1996).
As an antimicrobial, the bacteriocin, nisin, has numerous
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advantages over other available antimicrobial compounds.
Currently, it is a generally recognized as safe (GRAS) substance and approved for use in pasteurized processed cheese
spreads or pasteurized liquid whole egg. Nisin is stable under
refrigerated conditions, demonstrates heat stability, and is
degraded by gut enzymes. The spectrum of activity of this
compound not only includes Gram-positive pathogens such
as Clostridium botulinum, Staphylococcus aureus, Listeria monocytogenes or Bacillus cereus, but also meat spoilage organisms
(Brochothrix thermosphacta, Lactobacillus spp.). In these laboratories, it has previously been demonstrated that nisin can
effectively suppress the meat spoilage isolate, B. thermosphacta, when the bacteriocin is applied directly to the
meat surface (Cutter and Siragusa 1994a), immobilized in a
calcium alginate gel (Cutter and Siragusa 1996b, 1997), or
combined with vacuum packaging and refrigerated storage
(Cutter and Siragusa 1996a).
The objective of the following experiments was to determine if the bacteriocin, nisin, could be incorporated into a
meat binding system and reduce bacteria on fresh or vacuumpackaged meat surfaces. The application of an antimicrobial,
such as a bacteriocin, in Fibrimex® or similar products may
be useful for reducing undesirable bacteria in restructured
meat products made from whole muscles or trim that incorporate surface tissues into product interior.

MATERIALS AND METHODS

ments. Initial bacterial populations of approximately 3–4 log10
cfu cm−2 were obtained using this procedure.
Bacteriocin preparation and activity assays

Purified nisin (AmbicinTM, Applied Microbiology, New
York, USA) was solubilized in distilled water, filter-sterilized
(0·2 mm AcrodiscTM, Gelman Sciences, Ann Arbor, MI,
USA), added to sterile distilled water for a final stock concentration of 1 mg ml−1 (pH 6·0), and stored at −20 °C. Prior
to experiments, the stock solution was thawed to 25 °C and
diluted 1:100 in sterile distilled water or fibrinogen (Fibrimex®) solution for a final nisin concentration of 10 mg ml−1
used throughout the study.
Spot assays were performed on lawns of B. thermosphacta
to monitor bacteriocin activity in solutions containing nisin,
as well as stomachates, as previously described (Siragusa
1992). Samples of stomachates (10 ml) from all treated tissues
were used in spot assays. In addition to stomachates, Fibrimex® coatings and purge (liquid found in vacuum-packaged
meats) were assayed for nisin activity. Fibrimex® coatings
formed on F- and FN-treated tissues were aseptically scraped
from the vacuum package and placed onto a lawn of B.
thermosphacta. Samples of the purge (10 ml) from U- and Ntreated samples were used in spot assays as described above.
All plates were incubated for 18 h at 26 °C.
Treatments

Bacterial cultures and inoculation of beef

Brochothrix thermosphacta ATCC 11509 was maintained in
75% glycerol at −20 °C and propagated for 18 h in trypticase
soy broth (TSB; Troy Biologicals, Troy, MI, USA) at 26 °C.
For experiment 1, lean tissue (cutaneous trunci) from the
outer surfaces of pre-rigor (15 min post exsanguination) beef
carcasses was obtained from a local cow/bull processing plant,
placed in plastic bags, stored in insulated carriers to prevent
rapid cooling, transported to the Roman L. Hruska U.S.
Meat Animal Research Center (MARC), and used within 2 h
of slaughter. Prior to experiment 1, the cutaneous trunci was
trimmed to fit onto sterile trays. For experiment 2, postrigor, frozen, and thawed lean tissue (cutaneous trunci) was
cut to 7·5 cm × 7·5 cm. For both experiments, the surfaces
were surface sterilized by u.v. light (Cutter and Siragusa
1994b). Sterility was monitored by individually sampling
pieces of uninoculated tissue using the enumeration procedures described below. Overnight cultures of B. thermosphacta were diluted 1:1000 in sterile physiological saline
(pH 7·0) to obtain a viable cell population of approximately
6 log10 cfu ml−1. The inoculum was aseptically sprayed onto
the tissue with a hand-held sprayer (Ace Hardware) and left
undisturbed for 15 min, at 25 °C, prior to applying treat-

After inoculation with B. thermosphacta, tissue surfaces were
left untreated (U), or treated with Fibrimex® (F), nisin (N)
or Fibrimex®-nisin (FN). In both experiments, F, N and
FN treatments were performed at 25 °C by spraying the
compounds evenly over the tissues with a sterile hand-held
spray bottle and allowed to remain undisturbed for 5 min; F
samples were spray-treated with 7 ml fibrinogen (Fibrimex®),
followed by spray treatments with 3 ml thrombin (Fibrimex®), N samples were spray-treated with 7 ml nisin (10 mg
ml−1 concentration) and 3 ml sterile distilled water, and FN
samples were spray-treated with 7 ml fibrinogen-nisin (final
nisin concentration, 10 mg ml−1) and 3 ml thrombin. Following treatments in experiment 1, tissues were loosely covered with sterile aluminium foil and stored at 4 °C. Treated
tissues from experiment 2 were vacuum-packaged in u.v.treated, suitably-sized 3·2 ml nylon/copolymer bags with an
oxygen transmission rate at 23 °C of 52 cc m−2 (Hollymatic,
Countryside, IL, USA), vacuum-sealed using a Hollymatic
model LV 10 G, and stored at 4 °C.
Bacterial enumeration

A 25 cm2 piece was aseptically excised from the untreated or
treated tissues at 0, 1, 2 and 7 days of refrigeration for
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experiment 1 or 0, 1, 2, 7 and 14 days of refrigeration for
experiment 2. All individual samples were stomached for
2 min (Stomacher 400, Tekmar, Inc., Cincinnati, OH, USA)
in a SterefilTM Stomacher bag (Spiral Biotech, Bethesda, MD,
USA) with 25 ml of buffered peptone water (BPW, pH 7·0;
BBL, Cockeysville, MD, USA) containing 0·1% Tween-20
(Fisher, St Louis, MO, USA). Each stomachate was serially
diluted in BPW and either spiral-plated (Model D Spiral
Plater; Spiral Biotech) in duplicate or spread-plated in quadruplicate on STAA agar base (Oxoid) supplemented with
1·5% glycerol (Sigma), 50 mg ml−1 thallium acetate (Sigma),
500 mg ml−1 streptomycin sulphate (Sigma) and 50 mg ml−1
cycloheximide (Sigma). Plates were enumerated with CASBA
IV image analyser (Spiral Biotech) after incubation for 48 h
at 26 °C.
Calculations and statistical analyses

After enumeration, bacterial populations were converted to
log10 cfu cm−2. Least squared means (LSM) of bacterial
populations (log10 cfu cm−2) were calculated from six experimental replications for each experiment. Analysis of Variance
was performed using the General Linear Models procedure
of SAS (1988). Inoculum counts were used as a covariant
to normalize data between treatment replications. Statistical
significance was defined as P ¾ 0·05, unless otherwise noted.
RESULTS

In experiment 1, populations of B. thermosphacta remaining
on tissues subjected to N and FN treatments were statistically
similar and virtually undetectable (³0·50 log10 cfu cm−2) for
the 7 days of aerobic, refrigerated storage (Table 1). On all
days examined, populations of B. thermosphacta from N- and
FN-treated tissues were significantly different from U- and

Table 1 Experiment 1. Populations of Brochothrix thermosphacta

on lean beef tissue following treatments with nisin (10 mg
ml−1), Fibrimex® or Fibrimex®-nisin (10 mg ml−1) and aerobic
storage at 4 °C
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
Populations of Brochothrix thermosphacta (log10 cfu cm−2)
Treatment
Day 0
Day 1
Day 2
Day 7
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
Untreated
4·89a
4·98a
5·42a
8·01a
Fibrimex®
3·62a
4·02a
5·70a
8·44a
b
b
b
Nisin
0·00
0·00
0·23
0·30b
®
b
b
b
Fibrimex -nisin
0·00
0·00
0·00
0·00b
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
a,b,ab,bc,c
Different letters within column denote statistically
significant differences between treatments (P¾ 0·05). Each
value is the mean of six replications.

F-treated tissues, which were not significantly different from
one another. Bacteriocin assays performed on meat stomachates demonstrated that nisin was active in N and FN
samples through day 7 (Table 2).
In experiment 2, bacterial populations of B. thermosphacta
were effectively suppressed following treatments with N or
FN (Table 3) and vacuum-packaged, refrigerated storage for
up to 7 days. Populations of N- or FN-treated tissues were
not significantly different from each other except at day 1,
but both treatments were significantly different than U- and
F-treated tissues. By day 14, bacterial populations had
increased slightly on N- and FN-treated tissues, but were
significantly different than U- and F-treated tissues. Bacteriocin assays performed on meat stomachates demonstrated
that nisin was active in N and FN samples only through days
2 and 0, respectively (Table 2). Nisin activity from Fibrimex®
coatings through day 14 indicated that the bacteriocin was
still active (data not presented). Similarly, purge samples
from N-treated tissues up to 14 days also demonstrated nisin
activity (data not presented).
DISCUSSION

For the first time, it has been demonstrated that nisin can be
incorporated into a cold meat binding system and applied to
the surface of beef carcass tissue and have sustained antimicrobial activity, as indicated by reductions in bacterial
populations during aerobic or vacuum-packaged refrigerated
storage. While this system is not used specifically in restructured meat products, the results suggest that if antimicrobial
compounds such as bacteriocins are combined with a cold
meat binding system and applied to intact meat/muscle
surfaces, the shelf-life and/or microbiological stability of
restructured raw meat products may be improved.
The decrease in nisin activity exhibited in this study and
others (Bell and DeLacy 1986; Chung et al. 1989; Cutter
and Siragusa 1996a,b, 1997) is not fully understood. When
bacteriocins are applied directly to a meat surface, there are
several possibilities for diminished activity, including adsorption of nisin onto meat proteins or lipid particles, or assays
that are not sensitive enough to detect the bacteriocin in
samples (Tramer and Fowler 1964; Bell and DeLacy 1986).
While bacteriocin activity from nisin-treated tissues diminished over time in the present study, bacterial populations
remained suppressed compared to untreated controls, indicating that nisin was still active for the duration of the experiment.
Previously, it had been demonstrated that nisin could be
immobilized in calcium alginate gels on beef surfaces and
incorporated into ground beef (Cutter and Siragusa 1996a,b,
1997). As applied in that study, calcium alginate was used
solely as a delivery system for the antimicrobial and did not
impart any additional value or binding properties to the meat
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—
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Experiment 1a (Day)
Experiment 2b (Day)
—
–––––––––––––––––––––––––– —
–––––––––––––––––––––––––––––
Treatment
0
1
2
7
0
1
2
7
14
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Untreated
−c
−
−
−
−
−
−
−
−
®
Fibrimex
−
−
−
−
−
−
−
−
−
Nisin
¦d/6 ¦/6 ¦/4 ¦/5
¦/3 ¦/2 ¦/3 −
−
®
Fibrimex -nisin
¦/6 ¦/6 ¦/6 ¦/1
¦/4 −
−
−
−
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
a
Following treatment, samples were stored aerobically at 4 °C.
b
Following treatment, samples were vacuum-packed and stored at 4 °C.
c
Bacteriocin activity was not detected in stomachates.
d
Bacteriocin activity was detected in stomachates; number of positive samples from six
replications.

Table 3 Experiment 2. Populations of Brochothrix thermosphacta

on lean beef tissue following treatments with nisin (10 mg
ml−1), Fibrimex® or Fibrimex®-nisin (10 mg ml−1) and vacuumpackaged storage at 4 °C
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
Populations of Brochothrix thermosphacta (log10 cfu cm−2)
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
Treatment
Day 0
Day 1
Day 2 Day 7 Day 14
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
Untreated
3·58a
2·58a
2·78a 3·23a 4·56a
®
a
a
Fibrimex
3·29
2·82
2·90a 4·03a 5·17a
b
c
Nisin
0·48
0·00
0·00b 0·00b 1·94b
®
b
b
Fibrimex -nisin
0·00
1·02
0·50b 0·46b 2·18b
—
–––––––––––––––––––––––––––––––––––––––––––––––––––––
a,b,c
Different letters within column denote statistically significant
differences between treatments (P ¾ 0·05). Each value is the
mean of six replications.

product. The use of Fibrimex® as a delivery system for
antimicrobials to meat surfaces and possibly, to further processed or restructured meat products, may be more acceptable
than calcium alginate, given its binding properties, edible
nature and current approved use in meat products.
The addition of the bacteriocin, nisin, to a meat binding
system may provide an added antimicrobial advantage to
restructured raw meat products that incorporate surface tissues into product interior, or as a delivery system for antimicrobials to meat surfaces.
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Table 2 Presence or absence of nisin

activity from stomachates
obtained from untreated beef carcass
tissue, beef carcass tissue treated with
Fibrimex®, nisin (10 mg ml−1) or
Fibrimex®-nisin (10 mg ml−1)
and refrigerated storage (4 °C)
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